Evidence map›Paper›PMID 32715895›Full record

ArticleJournal of the American Heart Association2020

High Mortality Rates Among Patients With Non-Traumatic Intracerebral Hemorrhage and Atrial Fibrillation on Antithrombotic Therapy Are Independent of the Presence of Cerebral Amyloid Angiopathy: Insights From a Population-Based Study.

Shiva P Ponamgi, Robert Ward, Christopher V DeSimone, Stephen English, David O Hodge, Joshua P Slusser, Jonathan Graff-Radford, Alejandro A Rabinstein, Samuel J Asirvatham, David Holmes

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Shiva P PonamgiDivision of Hospital Internal Medicine Mayo Clinic Health System Austin MN.
Robert WardDivision of Internal Medicine Mayo Clinic Rochester MN.
Christopher V DeSimoneDivision of Cardiovascular Diseases Mayo Clinic Rochester MN.
Stephen EnglishDepartment of Neurology Emory University Atlanta GA.
David O HodgeDepartment of Health Sciences Research Mayo Clinic Jacksonville FL.
Joshua P SlusserDepartment of Health Sciences Research Mayo Clinic Rochester MN.
Jonathan Graff-RadfordDepartment of Neurology Mayo Clinic Rochester MN.
Alejandro A RabinsteinDepartment of Neurology Mayo Clinic Rochester MN.
Samuel J AsirvathamDivision of Cardiovascular Diseases Mayo Clinic Rochester MN.
David HolmesDivision of Cardiovascular Diseases Mayo Clinic Rochester MN.
Mayo Clinic in Arizona · USMayo Clinic · USEmory University · USMayo Clinic Health System · USMayo Clinic in Florida · US

Funding

Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
NIA NIH HHS R01 AG034676
6 · The paper itself

Abstract

Background Intracerebral hemorrhage (ICH) risk is higher in elderly patients with atrial fibrillation on antithrombotic therapy as well as those with cerebral amyloid angiopathy (CAA). We investigated if mortality among patients with atrial fibrillation on antithrombotic therapy presenting with non-traumatic ICH was influenced by underlying CAA. Methods and Results We used the Rochester Epidemiology Project to identify 6045 patients with atrial fibrillation aged >55 years on anticoagulation or antiplatelet therapy from 1995 to 2016. Seventy-four patients in this cohort presented with non-traumatic ICH. Medical records including imaging data were reviewed to identify those with CAA and record baseline variables and outcomes of interest; 38 of our 74 patients (51.4%) (mean age 81.5 years) met Modified Boston Criteria for possible or probable CAA. Twenty-six of 74 patients (35%) died during the first 30 days while 56 of the 74 (76%) patients died by 10 years follow-up after index ICH. Overall mortality was not significantly different between the CAA and non-CAA groups at any point of time during follow-up (

Indexed as

AgedAged, 80 and overAnticoagulantsAtrial FibrillationCerebral Amyloid AngiopathyCerebral HemorrhageFemaleHumansIncidenceMagnetic Resonance ImagingMaleMinnesotaRecurrenceRetrospective StudiesStrokeTomography, X-Ray ComputedAnticoagulantsanticoagulantsantiplatelet agentantithromboticsatrial fibrillationcerebral amyloid angiopathyintracerebral hemorrhage

Identifiers

PMID32715895
PMCPMC7792246
OpenAlexW3044619397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.